Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 35.60
-1.60 (-4.30%)
Apr 2, 2025, 5:24 PM IDT
TLV:TKUN Revenue
Tikun Olam-Cannbit Pharmaceuticals had revenue of 20.85M ILS in the half year ending June 30, 2024, a decrease of -1.41%. This brings the company's revenue in the last twelve months to 42.55M, down -16.05% year-over-year. In the year 2023, Tikun Olam-Cannbit Pharmaceuticals had annual revenue of 44.23M, down -10.28%.
Revenue (ttm)
42.55M
Revenue Growth
-16.05%
P/S Ratio
0.48
Revenue / Employee
850.92K
Employees
51
Market Cap
28.48M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 982.96M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |